Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Getty Images Reports First Quarter 2025 Results
-
Exodus Reports First Quarter 2025 Results
-
Maravai Lifesciences Reports First Quarter 2025 Financial Results
-
Brink's Delivers Strong First-Quarter Results
-
PennantPark Investment Corporation Announces Financial Results for the Quarter Ended March 31, 2025
-
Rigetti Computing Reports First Quarter 2025 Financial Results
-
Runway Growth Finance Corp. Reports First Quarter 2025 Financial Results
-
Middlefield Banc Corp. Announces 2025 Second-Quarter Cash Dividend Payment
-
Brink's Delivers Strong First-Quarter Results
-
Espey Mfg. & Electronics Corp. reports third quarter results
-
Beyond Oil Announces Exercise of Warrants and Purchase of Warrant Shares by Clal Insurance
-
Oncocyte Reports Q1 2025 Results and Business Progress
-
PennantPark Floating Rate Capital Ltd. Announces Financial Results for the Second Quarter Ended March 31, 2025
-
Hallador Energy Company Reports First Quarter 2025 Financial and Operating Results
-
VirTra Reports First Quarter 2025 Financial Results
-
Mineralys Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
Highwoods Announces Availability of 2024 Corporate Resiliency Report
-
Carbon Revolution Secures Further Release of $5m Million from OIC and further $0.4 Million Reserve Release from Existing Lenders
-
Lantronix Appoints Sailesh Chittipeddi to Its Board of Directors
-
FRP Holdings, Inc. (NASDAQ: FRPH) Announces Results for the First Quarter Ended March 31, 2025
-
Cue Biopharma Reports First Quarter 2025 Financial Results and Recent Business Highlights
-
Jasper Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
Gaia Reports First Quarter 2025 Results
-
Phunware Reports First Quarter 2025 Financial Results
-
Viasat Announces Appointments of Bill LaPlante and Michael Paull to Its Board of Directors
-
SKYX Announces Corporate Update Call Including New Developments
-
Rapid7 Announces First Quarter 2025 Financial Results
-
Akoya Biosciences Reports First Quarter 2025 Financial Results
-
Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
-
HF Foods Reports First Quarter 2025 Financial Results
-
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for AVMAPKI™FAKZYNJA™ CO-PACK
-
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
-
Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference
-
LifeMD to Participate in Three Investor Conferences During May
-
Amplify Energy Announces First Quarter 2025 Results, Beta Development Update and Updated Full-Year 2025 Guidance
-
Carbon Revolution Secures Further Release of $5m Million from OIC and further $0.4 Million Reserve Release from Existing Lenders
-
GigaCloud Technology Inc Announces First Quarter Ended March 31, 2025 Financial Results
-
Hour Loop Reports First Quarter of 2025 Results
-
Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
TPI Composites, Inc. Announces First Quarter 2025 Earnings Results – Operational Execution and Strategic Initiatives Drive Improved Financial Results; Initiation of Strategic Review
-
FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update
-
BLINK CHARGING ANNOUNCES FIRST QUARTER 2025 RESULTS
-
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
-
MidCap Financial Investment Corporation Reports Financial Results for the Quarter Ended March 31, 2025
-
Assertio Reports First Quarter 2025 Financial Results
-
HighPeak Energy, Inc. Announces First Quarter 2025 Financial and Operating Results
-
Stereotaxis Reports 2025 First Quarter Financial Results
-
Relmada Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
-
Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors

